A detailed history of Cognios Beta Neutral Large Cap Fund, LP transactions in Elevance Health, Inc. stock. As of the latest transaction made, Cognios Beta Neutral Large Cap Fund, LP holds 865 shares of ELV stock, worth $359,476. This represents 0.6% of its overall portfolio holdings.

Number of Shares
865
Previous 1,005 13.93%
Holding current value
$359,476
Previous $473,000 5.29%
% of portfolio
0.6%
Previous 0.64%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$464.61 - $519.96 $65,045 - $72,794
-140 Reduced 13.93%
865 $448,000
Q4 2023

Feb 02, 2024

SELL
$433.51 - $488.06 $52,888 - $59,543
-122 Reduced 10.83%
1,005 $473,000
Q3 2023

Nov 06, 2023

SELL
$414.13 - $475.93 $8,696 - $9,994
-21 Reduced 1.83%
1,127 $490,000
Q2 2023

Aug 03, 2023

SELL
$436.33 - $496.2 $73,739 - $83,857
-169 Reduced 12.83%
1,148 $510,000
Q1 2023

May 02, 2023

BUY
$446.3 - $502.2 $587,777 - $661,397
1,317 New
1,317 $605,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $99.7B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Cognios Beta Neutral Large Cap Fund, LP Portfolio

Follow Cognios Beta Neutral Large Cap Fund, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cognios Beta Neutral Large Cap Fund, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cognios Beta Neutral Large Cap Fund, LP with notifications on news.